Oric Pharmaceuticals, Inc. (ORIC) › Operating IncomeOric Pharmaceuticals, Inc. (ORIC) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2018: -$22.37M2019: -$28.57M2020: -$74.19M2021: -$78.87M2022: -$91.77M2023: -$110.78M2024: -$142.90M2025: -$143.00M-$143.00M2018Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$143.00M-0.1%2024-$142.90M-29.0%2023-$110.78M-20.7%2022-$91.77M-16.4%2021-$78.87M-6.3%2020-$74.19M-159.7%2019-$28.57M-27.7%2018-$22.37M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share